{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://trellisbio.com/#organization",
      "name": "Trellis - News",
      "url": "https://trellisbio.com/",
      "description": "Trellis - News --> ☰ Home --> Home News Science Technology Pipeline Bacteria Viruses Cancer Publications About Us Management Team Board of Directors Careers Press --> News updates from the Trellis Bioscience Team. May 2023 Press Release May 4, 2023 Trellis Bioscience Announces Clinical Proof of Concept in reducing biofilm burden in Prosthetic Joint Infections with a native human monoclonal antibody TRL1068 (View Press Release) Clinical proof-of-concept has been achieved for TRL1068 in a planned interim analysis based on completion of the second of three escalating dose groups 75% of chronic PJI patients treated with a single dose of TRL1068 and standard antibiotics had a bacterial biofilm bu"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/trellis-news#asg",
      "name": "Trellis - News ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/trellis-news",
      "isPartOf": {
        "@id": "https://trellisbio.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}